BioSpace News Archive

Exactech, a developer and producer of innovative implants, instrumentation and smart solutions for joint replacement surgery, announced today the launch of the Chime app.

Eurofins Technologies, a supplier of test kits and systems for laboratory analyses, announces the launch of the new SENSIStrip Allergen product range, which quickly detects allergens that must be labelled on packaged food products.

Today, the U.S. Food and Drug Administration approved a first-of-its-kind intentional genomic alteration (IGA) in a line of domestic pigs, referred to as GalSafe pigs, which may be used for food or human therapeutics. This is

The Prevnar 13® Vaccine Will Be Available to Members Beginning January 1, 2021

-Preclinical Data Published in Peer Reviewed Journals Support Advancing the Program into Human Clinical Trials- -Company Plans to Initiate Discussions with Regulatory Agencies in Early 2021 to Review Its Strategy for IND or Equivalent Filing-

HLS Therapeutics Inc. (“HLS” or the “Company”) (TSX:HLS), a specialty pharmaceutical company focusing on central nervous system and cardiovascular markets, today announced that Gilbert Godin, CEO, will present live at LifeSciencesInvestorForum.com on December 17 th . DATE: Thursday, December 17 th TIME: 11:30 AM ET LINK: https://bit.ly/3mPSVkO This will be a live, interactive online event where investors are invited to ask the company

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has contracted to sell all 2020 grain production of its high oleic soybean to ADM (NYSE: ADM), a global leader in human and animal nutrition and the world’s premier agricultural origination and processing company headquartered in Chicago

Healthycell is making its entrance into retail by launching its MICROGEL™ line of supplements, including REM Sleep, Bioactive Multi, and Vegan Essentials, at each of the six distinct Erewhon locations.

Applied UV, Inc., an infection prevention technology company that applies the power of narrow-range ultraviolet light to destroy pathogens safely, thoroughly, and automatically, announced that Rhonda A. Wallen has joined the Company as Vice President of Product Marketing & Corporate Development.

Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the appointment of Dawn Svoronos as an independent member of Adverum’s Board of Directors. Ms. Svoronos has three decades of global biopharmaceutical industry experience, spanning the United States, Canada, Europe, and Asia, gained during her 25-year career at Merck & Co. “D